Skip to main content
SpringerLink
Log in

Complement Deficiencies

  • Chapter
Primary Immunodeficiency Diseases

  • 1385 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH (1971) Deficiency of C3 inactivator in man. J Immunol 107:19–27

    PubMed  CAS  Google Scholar 

  2. Agostoni A, Cicardi M (1992) Hereditary and acquired C1-inhibitor deficiency: biologic and clinical characteristics in 235 patients. Medicine (Baltimore) 71:206–215

    CAS  Google Scholar 

  3. Amadei N, Baracho GV, Nudelman V, Bastos W, Florido MP, Isaac L (2001) Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H. Scand J Immunol 53:615–621

    Article  PubMed  CAS  Google Scholar 

  4. Atkinson JP (1989) Complement deficiency: predisposing factor to autoimmune syndromes. Clin Exp Rheumatol 7:95–101

    Google Scholar 

  5. Atkinson JP, Schneider PM (1999) Genetic susceptibility and class III complement genes. In: Lahita RG (ed) Systemic lupus erythematosus. Academic Press, San Diego, pp 91–104

    Google Scholar 

  6. Ault BH (2000) Factor H and the pathogenesis of renal diseases. Pediatr Nephrol 14:1045–1053

    Article  PubMed  CAS  Google Scholar 

  7. Bala Subramanian V, Liszewski MK, Atkinson JP (2000) The complement system and autoimmunity. In: Lahita RG, Chiorazzi N, Reeves W (eds) Textbook of autoimmune diseases, Lippincott-Raven, Philadelphia

    Google Scholar 

  8. Barilla-LaBarca ML, Atkinson JP (2003) Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol 15:55–60

    Article  PubMed  CAS  Google Scholar 

  9. Biesma DH, Hannema AJ, van Velzen-Blad H, Mulder L, van Zwieten R, Kluijt I, Roos D (2001) A family with complement factor D deficiency. J Clin Invest 108:233–240

    PubMed  CAS  Google Scholar 

  10. Blanch A, Roche O, Urrutia I, Gamboa P, Fontan G, Lopez-Trascasa M (2006) First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol 118:1330–1335

    Article  PubMed  Google Scholar 

  11. Bowen B, Hawk JJ, Sibunka S (2001) A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. Clin Immunol 87:157–163

    Article  Google Scholar 

  12. Bowness P, Davies KA, Norsworthy PJ, Athanassiou P, Taylor-Wiedeman J, Borysiewicz LK, Meyer PA, Walport MJ (1994) Hereditary C1q deficiency and systemic lupus erythematosus. Q J Med 87:455–464

    CAS  Google Scholar 

  13. Carroll MC (2004) A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 4:825–831

    Article  PubMed  CAS  Google Scholar 

  14. Cicardi M, Agostoni A (1996) Hereditary angioedema. N Engl J Med 334:1666–1667

    Article  PubMed  CAS  Google Scholar 

  15. Colten HR, Rosen FS (1992) Complement deficiencies. Annu Rev Immunol 10:809–834

    Article  PubMed  CAS  Google Scholar 

  16. Cooper NR, Morrison DC (1978) Binding and activation of the first component of complement by the lipid A region of lipopolysaccharides. J Immunol 120:1862–1868

    PubMed  CAS  Google Scholar 

  17. Davies EG (1998) Immunodeficiency. In: Campbell AGM, McIntosh N (eds) Forfar and Arneil’s textbook of paediatrics. Churchill Livingstone, London, p 1262

    Google Scholar 

  18. Davis AEI (1998) C1 inhibitor gene and hereditary angioedema. In: Volanakis JE, Frank MM (eds) The human complement system in health and disease. Marcel Dekker, New York, pp 229–244

    Google Scholar 

  19. Densen P, Weiler J, Griffiss J, Hoffman L (1996) Functional and antigenic analysis of human factor B deficiency. Mol Immunol 33:6820. Donaldson VH, Bissler JJ (1992) C1 inhibitors and their genes: an update. J Lab Clin Med 119:330–333

    Google Scholar 

  20. Ember JA, Jagels MA, Hugli TE (1998) Characterization of complement anaphylatoxins and their biological responses. In: Volanakis JE, Frank MM (eds) The human complement system in health and disease. Marcel Dekker, New York, pp 241–284

    Google Scholar 

  21. Fasano M, Hamosh A, Winkelstein J (1990) Recurrent systemic bacterial infections in homozygous C2 deficiency. Pediatr Allergy Immunol 1:46–49

    Article  Google Scholar 

  22. Fijen CAP, von den Bogaard R, Schipper M (1999) Properdin deficiency: molecular basis and disease association. Mol Immunol 36:863–868

    Article  PubMed  CAS  Google Scholar 

  23. Figueroa J, Andreoni J, Densen P (1993) Complement deficiency states and meningococcal disease. Immunol Res 12:295–311

    Article  PubMed  CAS  Google Scholar 

  24. Figueroa JE, Densen P (1991) Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4:359–395

    PubMed  CAS  Google Scholar 

  25. Frangi D, Cicardi M, Sica A (1991) Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioedema. J Clin Invest 88:755–759

    Article  PubMed  CAS  Google Scholar 

  26. Frank MM (1993) Hereditary angioedema. In: Whaley K, Loos MM and Weiler JM (eds) Complement in health and disease. Kluwer, Netherlands

    Google Scholar 

  27. Frank MM (2000) Complement deficiencies. Pediatr Clin North Am 47:1339–1354

    Article  PubMed  CAS  Google Scholar 

  28. Frank MM, Gelfrand F, Atkinson JP (1976) Hereditary angioedema: clinical syndrome and its management. Ann Intern Med 84:580–593

    PubMed  CAS  Google Scholar 

  29. Fukumori Y, Yoshimura K, Ohnoki S, Yamaguchi H, Akagaki Y, Inai S (1989) A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan. Int Immunol 1:85–89

    Article  PubMed  CAS  Google Scholar 

  30. Garred P, Pressler T, Madsen HO (1999) Association of mannose-binding lectin gene heterogeneity with severity of disease and survival in cystic fibrosis. J Clin Invest 104:431–437

    Article  PubMed  CAS  Google Scholar 

  31. Garred P, Madsen HO, Marquart H, Hansen TM, Sørensen SF, Petersen J, Volck B, Svejgaard A, Graudal NA, Rudd PM, Dwek RA, Sim RB, Andersen V (2000) Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol 27:26–34

    PubMed  CAS  Google Scholar 

  32. Giclas PC, Pinckard RN, Olson MS (1979) In vitro activation of human complement by isolated human heart subcellular membranes. J Immunol 122:146

    PubMed  CAS  Google Scholar 

  33. Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, Carreras L, Arranz EA, Garrido CA, López-Trascasa M, Sánchez-Corral P, Morgan BP, Rodríguez de Córdoba S (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A. 104:240–245. Erratum in: Proc Natl Acad Sci USA 104:10749

    Article  Google Scholar 

  34. Gompels MM, Lock RJ (2005) C1 inhibitor deficiency: diagnosis. Clin Exp Dermatol 30:460–462

    Article  PubMed  CAS  Google Scholar 

  35. Goonewardena P, Sjöholm AG, Nilsson LA, Pettersson U (1988) Linkage analysis of the properdin deficiency gene: suggestion of a locus in the proximal part of the short arm of the X chromosome. Genomics 2:115–118

    Article  PubMed  CAS  Google Scholar 

  36. Hellemann D, Larsson A, Madsen HO, Bonde J, Jarlø JO, Wiis J, Faber T, Wetterslev J, Garred P (2007) Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Hum Mol Genet 16:3071–3080

    Article  PubMed  CAS  Google Scholar 

  37. Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, Roth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Eng J Med 355:1233–1243

    Article  CAS  Google Scholar 

  38. Hoare S, El-Shazali O, Clark JE, Fay A, Cant AJ (2002) Investigation for complement deficiency following meningococcal disease. Arch Dis Child 86:215–217

    Article  PubMed  CAS  Google Scholar 

  39. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12:682–687

    Article  PubMed  CAS  Google Scholar 

  40. Hugli TE (1986) Biochemistry and biology of anaphylatoxins. Complement 3:111–127

    PubMed  CAS  Google Scholar 

  41. Ihara S, Takahashi A, Hatsuse H, Sumitomo K, Doi K, Kawakami M (1991) Major component of Ra-reactive factor, a complement-activating bactericidal protein, in mouse serum. J Immunol 146:1874–1879

    PubMed  CAS  Google Scholar 

  42. Inai S, Akagaki Y, Moriyama T, Fukumori Y, Yoshimura K, Ohnoki S, Yamaguchi H (1989) Inherited deficiencies of the late-acting complement components other than C9 found among healthy blood donors. Int Arch Allergy Appl Immunol 90:274–279

    Article  PubMed  CAS  Google Scholar 

  43. Johnson CA, Densen P, Wetsel RA (1992) Molecular heterogeneity of C2 deficiency. N Engl J Med 326:871–874

    Article  PubMed  CAS  Google Scholar 

  44. Jönsson G, Truedsson L, Sturfelt G, Oxelius VA, Braconier JH, Sjöholm AG (2005) Homozygous C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis and rheumatic disease. Medicine (Baltimore) 84:23–34

    Article  Google Scholar 

  45. Kaplan AP, Greaves MW (2005) Angioedema. J Am Acad Dermatol 53:373–88

    Article  PubMed  Google Scholar 

  46. Kawasaki N, Kawasaki T, Yamashina I (1989). A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J Biochem Tokyo 106:483–489

    PubMed  CAS  Google Scholar 

  47. Kilpatrick DC (2002) Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 15772:401–413

    Google Scholar 

  48. Kimura Y, Miwa T, Zhou L, Song WC (2008) Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111:732–740

    Article  PubMed  CAS  Google Scholar 

  49. Kovarik J, Siegrist CA (1998) Immunity in early life. Immunol Today 19:150–152

    Article  PubMed  CAS  Google Scholar 

  50. Lachmann PJ, Thompsen RA (1970) Reactive lysis: the complement mediated-lysis of unsensitized cells—the characterization of activated reactor as C5b and the participation of C8 and C9. J Exp Med 131:643–657

    Article  PubMed  CAS  Google Scholar 

  51. Lachmann PJ, Nichol PAE (1973) Reaction mechanism of the alternative pathway of complement fixation. Lancet 1: 465–467

    Article  PubMed  CAS  Google Scholar 

  52. Lambris JD (1988) The multifunctional role of C3. The third component of complement. Immunol Today 9:387–393

    Article  PubMed  CAS  Google Scholar 

  53. Law SKA, Reid KBM (1995) Activation and control of the complement system. In: Male D (ed) In focus: complement. Oxford University Press, Oxford, pp 11–28

    Google Scholar 

  54. Leitão MF, Vilela MMS, Rutz R, Grumach AS, Condino-Neto A, Kirschfink M (1997) Complement factor I deficiency in a family with recurrent infections. Immunopharmacology 38:207–213

    Article  PubMed  Google Scholar 

  55. Liszewski MK, Atkinson JP (1993) The complement system. In: Paul WE (ed) Fundamental immunology. Raven Press, New York

    Google Scholar 

  56. Liszewski MK, Farries TC, Lublin DM (1996) Control of the complement system. Adv Immunol 61:201–283

    Article  PubMed  CAS  Google Scholar 

  57. Marder HK, Coleman TH, Forristal J, Beischel L, West CD (1983) An inherited defect in the C3 convertase, C3b, Bb, associated with glomerulonephritis. Kidney Int 23:749–758

    Article  PubMed  CAS  Google Scholar 

  58. Markovic SN, Inwards DJ, Phyliky RP (2000) Acquired C1 esterase inhibitor deficiency. Ann Intern Med 133:839

    Google Scholar 

  59. Mathieson P (2002) Complement factor H and haemolytic uraemic syndrome. Lancet 359:801–802

    Article  PubMed  Google Scholar 

  60. Matsushita M (1996) The lectin pathway of the complement system. Microbiol Immunol 40:887–893

    PubMed  CAS  Google Scholar 

  61. Mollnes TE, Song WC, Lambris JD (2002) Complement in inflammatory tissue damage and disease. Trends Immunol 23:61–64

    Article  PubMed  CAS  Google Scholar 

  62. Morley BJ, Walport MJ (2000) The complement system. In: Morley BJ, Walport MJ (eds) The complement facts book. Academic Press, New York, pp 7–22

    Chapter  Google Scholar 

  63. Naked GM, Florido MP, Ferreira de Paula P, Vinet AM, Inostroza JS, Isaac L (2000) Deficiency of human complement factor I associated with lowered factor H. Clin Immunol 96:162–167

    Article  PubMed  CAS  Google Scholar 

  64. Navratil JS, Korb LC, Ahearn JM (1999) Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance. Immunopharmacology 42:47–52

    Article  PubMed  CAS  Google Scholar 

  65. Nishino H, Shibuya K, Nishida Y, Mushimoto M (1981) Lupus erythematosus-like syndrome with selective complete deficiency of C1q. Ann Intern Med 95:322–324

    PubMed  CAS  Google Scholar 

  66. Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G; International Registry of Recurrent and Familial HUS/TTP (2003) Familial haemolytic uraemic syndrome and an MCP mtuation. Lancet 362:1542–1547

    Article  PubMed  CAS  Google Scholar 

  67. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-edema. Lancet 351:1693–1697

    Article  PubMed  CAS  Google Scholar 

  68. Øhlenschlaeger T, Garred P, Madsen HO, Jacobsen S (2004) Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351:260–267

    Article  PubMed  Google Scholar 

  69. Oltvia ZN, Wong ECC, Atkinson JP (1991) C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema. Lab Invest 65:381–388

    Google Scholar 

  70. O’Neil KM (2000) Complement deficiency. Clin Rev Allergy Immunol 19:83–108

    Article  PubMed  Google Scholar 

  71. Pangburn MK, Muller-Eberhard HJ (1980) Relation of a putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement. J Exp Med 152:1102–1114

    Article  PubMed  CAS  Google Scholar 

  72. Petersen SV, Thiel S, Jensen L, Vorup-Jensen T, Koch C, Jensenius JC (2000) Control of the classical and the MBL pathway of complement activation. Mol Immunol 37:803–811

    Article  PubMed  CAS  Google Scholar 

  73. Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC (2001) An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods 257:107–116

    Article  PubMed  CAS  Google Scholar 

  74. Petry F (1998) Molecular basis of hereditary C1q deficiency. Immunobiology 199:286–294

    PubMed  CAS  Google Scholar 

  75. Pickering M, Walport MJ (2000) Links between complement abnormalities and systemic lupus erythematosus. Rheumatology 39:133–141

    Article  PubMed  CAS  Google Scholar 

  76. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227–324

    Article  PubMed  CAS  Google Scholar 

  77. Platts-Mills TAE, Ishizaka K (1974) Activation of the alternative pathway of human complement by rabbit cells. J Immunol 113:358

    Google Scholar 

  78. Podack ER (1986) Assembly and function of the terminal components. In: Ross GD (ed) Immunobiology of the complement system. Academic Press, Orlando, pp 115–137

    Google Scholar 

  79. Rabson A (1997) Complement activation. In: Rose NR, Conway de Macario E, Folds JD, Lane HC, Nakamura RM (eds) Manual of clinical laboratory immunology. ASM Publications, Washington, pp 187–191

    Google Scholar 

  80. Reis ES, Falcao DA, Isaac L (2006) Clinical Aspects and Molecular Basis of Primary Deficiencies of Complement Component C3 and its Regulatory Proteins Factor I and Factor H. Scand J Immunol 63:155–168

    Article  CAS  Google Scholar 

  81. Richards A, Goodship JA, Goodship TH (2002) The genetics and pathogenesis of haemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Curr Opin Nephrol Hypertens 11:431–435

    Article  PubMed  Google Scholar 

  82. Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Müslümanoǧlu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 100:12966–12971

    Article  PubMed  CAS  Google Scholar 

  83. Ross SC, Densen P (1984) Complement deficiency states and infection: epidemiology, pathogenesis and consequences of Neisserial and other infections in an immune deficiency. Medicine 63:243–273

    Article  PubMed  CAS  Google Scholar 

  84. Rougier N, Kazatchkine MD, Rougier J-P, Fremeaux-Bacchi V, Blouin J, Deschenes G, Soto B, Baudouin V, Pautard B, Proesmans W, Weiss E, Weiss L (1998) Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrology 9:2318–2326

    CAS  Google Scholar 

  85. Rugonfalvi-Kiss S, Endrész V, Madsen HO, Burián K, Duba J, Prohászka Z, Karádi I, Romics L, Gönczöl E, Füst G, Garred P (2002) Association of Chlamydia pneumonia with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 106:1071–1076

    Article  PubMed  CAS  Google Scholar 

  86. Sakamato M, Fujisawa Y, Nishioka K (1998) Physiologic role of the complement system in host defense, disease, and malnutrition. Nutrition 14:391–398

    Article  Google Scholar 

  87. Schifferli JA, Taylor RP (1989) Physiologic and pathologic aspects of circulating immune complexes. Kidney Int 35:993–1003

    Article  PubMed  CAS  Google Scholar 

  88. Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjöholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR (2005) Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Meth 296:187–198

    Article  CAS  Google Scholar 

  89. Sim RB, Arlaud GJ, Colomb MG (1979) C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes. Biochem J 179:449–457

    PubMed  CAS  Google Scholar 

  90. Sinclair D, Smith A, Cranfield T, Lock RJ (2004) Acquired C1 esterase inhibitor deficiency or serendipity? The chance finding of a paraprotein after an apparently low C1 esterase inhibitor concentration. J Clin Pathol 57:445–447

    Article  PubMed  CAS  Google Scholar 

  91. Sjöholm AG (2002) Deficiencies of mannose-binding lectin, the alternative pathway, and the late complement components. In: Rose NR, Hamilton RG, Detrick B (eds) Manual of Clinical Laboratory Immunology. ASM Press, Washington, pp 847–854

    Google Scholar 

  92. Sjöholm AG, Jönsson G, Braconier JH, Sturfelt G, Truedsson L (2006) Complement deficiency and disease: an update. Mol Immunol 43:78–85

    Article  PubMed  CAS  Google Scholar 

  93. Spitzer D, Mitchell LM, Atkinson JP, Hourcade DE (2007) Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 179:2600–2608

    PubMed  CAS  Google Scholar 

  94. Sprong T, Roos D, Weemaes C, Neeleman C, Geesing CL, Mollnes TE, van Deuren M (2006) Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. Blood 107:4865–4870

    Article  PubMed  CAS  Google Scholar 

  95. Stengaard-Pedersen K, Thiel S, Gadjeva M, Møller-Kristensen M, Sørensen R, Jensen LT, Sjøholm AG, Fugger L, Jensenius JC (2003) Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med. 349:554–560

    Article  PubMed  CAS  Google Scholar 

  96. Sullivan KE (1998) Complement deficiency and autoimmunity. Curr Opin Pediatr 10:600–606

    Article  PubMed  CAS  Google Scholar 

  97. Suzuki Y, Ogura Y, Otsubo O, Akagi K, Fujita T (1992) Selective deficiency of C1s associated with a systemic lupus erythematosus-like syndrome. Arthritis Rheum 35:576–578

    Article  PubMed  CAS  Google Scholar 

  98. Taylor CM (2001) Complement factor H and the haemolytic uraemic syndrome. Lancet 358:1200–1202

    Article  PubMed  CAS  Google Scholar 

  99. Valdimarson H, Vikingsdottir T, Bang P, Saevarsdottir S, Gudjonsson JE, Oskarsson O, Christiansen M, Blou L, Laursen I, Koch C (2004). Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol. 59:97–102

    Article  Google Scholar 

  100. Vyse TJ, Späth PJ, Davies KA, Morley BJ, Philippe P, Athanassiou P, Giles CM, Walport MJ (1994). Hereditary complement factor I deficiency. Q J Med 87:385–401

    CAS  Google Scholar 

  101. Walport MJ (2001) Complement: first of two parts. N Engl J Med 344:1058–1066

    Article  PubMed  CAS  Google Scholar 

  102. Walport MJ (2001) Complement: second of two parts. N Engl J Med 344:1140–1144

    Article  PubMed  CAS  Google Scholar 

  103. Walport MJ, Davies KA, Botto M (1998) C1q and systemic lupus erythematosus. Immunobiology 199:265–285

    PubMed  CAS  Google Scholar 

  104. Welch TR, Frenzke M (2001) Glomerulonephritis associated with deficiencies and polymorphisms of complement components encoded in the class III region of the MHC. Front Biosci 6:D898–903

    Article  PubMed  CAS  Google Scholar 

  105. Wen L, Atkinson JP, Giclas PC (2004) Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 113:585–593

    Article  PubMed  CAS  Google Scholar 

  106. Winkelstein JA (1994) Complement deficiencies. In: Oski FA (ed) Principles and practice of pediatrics. Lippincott, Philadelphia, pp 188–191

    Google Scholar 

  107. Würzner R (2003) Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal deficiency of particular evolutionary benefit. Clin Exp Immunol 133:156–159

    Article  PubMed  Google Scholar 

  108. Yu CY, Blanchong CA, Chung EK, Rupert KL, Yang Y, Yang Z, Zhou B, Moulds JM (2002) Molecular genetic analysis of human complement components C4A and C4B. In: Rose NR, Hamilton RG, Detrick B (eds) Manual of clinical laboratory immunology. ASM Press, Washington, pp 117–131

    Google Scholar 

  109. Ziccardi RJ, Cooper NR (1979) Active disassembly of the first complement component, C1, by C1 inactivator. J Immunol 123:788–792

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nutrition and Biochemistry School of Public Health and Institute of Public Health Research, Tehran University of Medical Sciences, Tehran, 14147, Iran

    Maryam Mahmoudi MD

  2. Institute of Immunology Rikshospitalet University Hospital, University of Oslo, N-0027, Oslo, Norway

    Tom Eirik Mollnes MD, PhD

  3. Division of Pediatric Hematology, Immunology and Infectious diseases Emma Children’s Hospital Academic Medical Center, University of Amsterdam, 1105, AZ Amsterdam, The Netherlands

    Taco W. Kuijpers MD, PhD

  4. Department of Blood Cell Research Sanquin Research and Landsteiner Laboratory, University of Amsterdam, 1066, CX Amsterdam, The Netherlands

    Taco W. Kuijpers MD, PhD

  5. Department of Blood Cell Research Sanquin Research and Landsteiner Laboratory Academic Medical Center, University of Amsterdam, 1066, CX Amsterdam, The Netherlands

    Dirk Roos PhD

Authors
  1. Maryam Mahmoudi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tom Eirik Mollnes MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Taco W. Kuijpers MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dirk Roos PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Immunology, Asthma and Allergy Research Institute Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, 14194, Iran

    Nima Rezaei

  2. Section of Infection, Inflammation and Immunity School of Medicine and Biomedical Sciences, The University of Sheffield, S10 2RX, Sheffield, UK

    Nima Rezaei

  3. Division of Allergy and Clinical Immunology Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, 14194, Iran

    Asghar Aghamohammadi

  4. Division of Immunology Children’s Hospital, Harvard Medical School, Boston, MA, 02115, USA

    Luigi D. Notarangelo

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mahmoudi, M., Mollnes, T.E., Kuijpers, T.W., Roos, D. (2008). Complement Deficiencies. In: Rezaei, N., Aghamohammadi, A., Notarangelo, L.D. (eds) Primary Immunodeficiency Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78936-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78936-9_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78537-8

  • Online ISBN: 978-3-540-78936-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation